fda crackdown on compounded semaglutide issued 25 warning letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA crackdown on off-brand Ozempic

Cannarile MA, Weisser M, Jacob W, Jegg AM, Ries CH, Rttinger D

As a consequence, IGF-1 is synthesized and secreted at suboptimal levels

Excessive production of highly reactive molecules such as ROS and reactive nitrogen species (RNS) leads to the inhibition of antioxidant capacity, which tilts the equilibrium toward oxidation, resulting in oxidative stress

Clinicians should characterize the bleeding pattern: color (bright red versus dark), volume, frequency, relationship to bowel movements, and associated symptoms

Der erste zur Behandlung von Adipositas und bergewicht mit Begleiterkrankungen zugelassene GLP-1-Rezeptoragonist war Liraglutid (Saxenda) (EU-Zulassung 2015)